The future of error detection in cancer looks promising with advances in artificial intelligence (AI) and machine learning to analyze large datasets and identify patterns that may be missed by traditional methods. Additionally, personalized medicine approaches that tailor treatments based on an individual's genetic makeup hold significant potential.
